logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chan Y. Cheah

Sir Charles Gairdner Hospital
H指数:48
被引数:9,264

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma

LTB-TREAT：一种用于低肿瘤负荷滤泡性淋巴瘤治疗时间预测的国际验证性预后模型

British Journal of Haematology
IF3.8
2026-08-300
OAAI
Luani Barge; Lachlan Webb; Anita Pelecanos; Niamh Waters; Ross Salvaris; Sam Lai; Tessa Potezny; Helen Cashman; Caitlyn Nguyen-Ngo; Denise Lee; Costas K. Yannakou; Nada Hamad; Adrien Chauchet; Sylvain Choquet; Cédric Rossi; Adélie Herbin; Lukshe Kanagaratnam; Cyrielle Rodier; Constantine S. Tam; Abir Bhattacharyya; Chan Y. Cheah; Eliza A. Hawkes; Kirk Morris; Eric Durot; Joshua Tobin; Greg Hapgood
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO

戈利妥昔单抗联合吉西他滨和奥沙利铂治疗复发/难治性弥漫大B细胞淋巴瘤：STARGLO研究的3年随访

Blood Advances
IF7.1
2026-06-130
OAAI
Jeremy S. Abramson; William Townsend; Christopher P. Fox; Matthew Ku; Mark Hertzberg; Hui-Qiang Huang; Huilai Zhang; Dok Hyun Yoon; Won-Seog Kim; Haifaa Abdulhaq; Charles Herbaux; Jan M. Zaucha; Qing-Yuan Zhang; Hung Chang; Yanyan Liu; Chan Yoon Cheah; Herve Ghesquieres; Estefania Mulvihill; Murali Kesavan; Martine Kallemeijn
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study

奥比妥珠单抗、来那度胺和维奈克拉用于晚期滤泡性淋巴瘤患者初始治疗：LEVERAGE Ib/II期研究的结果

HemaSphere
IF14.6
2026-06-070
OAAI
Chan Y. Cheah; Piers Blombery; Amanda Johnston; Joel Wight; Katharine L. Lewis; Rory Bennett; Jing Xie; Stella Vlachos; Sally M. Hunter; Joyce Gonzales; Sally Binks; John F. Seymour
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy

滤泡性淋巴瘤接受免疫化疗的治疗诊断至治疗间隔与结局相关

Blood
IF23.1
2026-04-160
PRE
Prokop Vodička; Tarec Christoffer El-Galaly; Vít Procházka; Christopher R Flowers; Diego Villa; Caroline E Dietrich; Lasse H Jakobsen; Hervé Ghesquières; Michael R Clausen; Robert Kridel; Chan Y Cheah; Eliza A Hawkes; Björn Wahlin; Maher K Gandhi; Melissa C Larson; Elliot J Cahn; Jonathan W Friedberg; Peter Martin; Dai Chihara; Jonathon B Cohen
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.

Mosunetuzumab单药治疗在复发/难治性Richter’s transformation患者中是有效的且可耐受的。

Blood Advances
IF7.1
2026-02-090
OAAI
Katharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN Study

Pirtobrutinib，R/R边缘区淋巴瘤中的高选择性，非共价 (可逆) BTKi: 1/2期布鲁因研究

Blood Advances
IF7.1
2026-01-200
OAAI
Krish Patel; Julie Vose; Sunita D. Nasta; Jennifer R. Brown; Kami Maddocks; Jennifer Woyach; Nirav N. Shah; Bita Fakhri; Benoit Tessoulin; Shuo Ma; Deepa Jagadeesh; Ewa Lech-Maranda; Catherine C. Coombs; Manish R. Patel; Joanna M. Rhodes; Chaitra Ujjani; Marc S. Hoffmann; Chan Y. Cheah; Talha Munir; David Lewis
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

EHA–EU MCL网络关于套细胞淋巴瘤诊断与治疗指南

HemaSphere
IF14.6
2025-10-220
OAAI
Mats Jerkeman; Igor Aurer; Elias Campo; Chan Y. Cheah; Jonathan Clark; Jeanette Doorduijn; Toby A. Eyre; Martin Fehr; Eva Giné; Maria Gomes da Silva; Pavel Klener; Marco Ladetto; Vincent Ribrag; Ofer Shpilberg; Jan Walewski; Martin Dreyling; the EHA Guidelines Committee and the European MCL Network
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia

Pirtobrutinib对复发/难治性慢性淋巴细胞白血病的反应和耐药性的基因组决定因素

Blood
IF23.1
2025-10-100
OAAI
Jennifer R. Brown; Bastien Nguyen; Sai Prasad Desikan; Helen Won; Shady I. Tantawy; Samuel C. McNeely; Narasimha Marella; Hetal S. Randeria; Lauren M. Hanson; Andrew Parker; Salomé Calado Botelho; Jennifer A. Woyach; Krish Patel; Constantine S. Tam; Toby A. Eyre; Chan Y. Cheah; Nirav N. Shah; Paolo Ghia; Wojciech Jurczak; Minna Balbas; Binoj Nair; Paolo Abada; Chunxiao Wang; Denise Wang; Lindsey E. Roeker; Varsha Gandhi; William G. Wierda
Meeting trial eligibility in Follicular lymphoma patients is associated with overall survival but not progression-free survival

滤泡性淋巴瘤患者满足临床试验入组标准与总生存期相关，但与无进展生存期无关。

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-09-011
PRE
Wong, Kimberly S. Q.; Martynchyk, Arina; Krisnadi, Zoe; Swain, Fiona; Zargari, Ahmad; Cassidy, Luke; Mills, Georgia; Lim, Kenneth; Gervasi, Jeremy; Smallbone, Portia; Wang, Jenny; Slifirski, Olivia; Loh, Zoe; Cheah, Chan; Keane, Colm; Gregory, Gareth; Lasica, Masa; Chong, Geoffrey; Barraclough, Allison; Cochrane, Tara; Lee, Denise; Hawkes, Eliza
Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory (R/R) Indolent NHL: Results from the Phase 1 CaDAnCe-101 Study

初步有效性和安全性：Bruton酪氨酸激酶降解剂BGB-16673在复发或难治性(R/R)惰性非霍奇金淋巴瘤(NHL)患者中的研究；来自第1期CaDAnCe-101试验的结果

BLOOD
IF23.1
2024-11-051
PRE
Tam, Constantine S.; Frustaci, Anna Maria; Bijou, Fontanet; Zinzani, Pier Luigi; Seymour, John F.; Lasica, Masa; Eradat, Herbert A.; Lin, Victor T. G.; Alwan, Maan; Mocanu, Irina; Chen, Xiangmei; By, Kunthel; Fabre, Shannon; Persky, Daniel O.; Agarwal, Amit; Cheah, Chan Y.
Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study

体重指数与澳大利亚及大洋洲淋巴瘤患者的临床关联：一项淋巴瘤及相关疾病登记研究

BLOOD
IF23.1
2024-11-050
PRE
Sungur, Serif; Yao, Yao; Wellard, Cameron; Chung, Eliza; Morgan, Susan; Lee, Denise; Chong, Geoffrey; Cheah, Chan Y.; Rizvi, Tasneem; Hawkes, Eliza A.; Mcquilten, Zoe K.; Wood, Erica M.; Hamad, Nada; Armytage, Tasman; Johnston, Anna M.

研究方向

暂未获取到该数据
J
John F. Seymour
H 指数:111论文数:995被引数:5.4万
C
Constantine S. Tam
H 指数:76论文数:873被引数:2.9万
N
Nathan Fowler
H 指数:62论文数:580被引数:1.8万
E
Eliza A. Hawkes
H 指数:28论文数:323被引数:3,275
W
Wojciech Jurczak
H 指数:57论文数:649被引数:2.0万
D
Diego Villa
H 指数:44论文数:352被引数:7,361
T
Tarec Christoffer El‐Galaly
H 指数:37论文数:347被引数:4,431
T
Toby A. Eyre
H 指数:39论文数:386被引数:5,705
P
Paolo Ghia
H 指数:93论文数:1,080被引数:3.6万
N
Nirav N. Shah
H 指数:46论文数:537被引数:9,088